SLC10A2 and familial intrahepatic cholestasis: Maralixibat is an ileal bile acid transporter (IBAT) inhibitor approved for the treatment of rare cholestatic liver diseases, including Alagille syndrome, progressive familial intrahepatic cholestasis and biliary atresia.